This compound is a chemical compound used as a pharmaceutical intermediate. It is primarily significant in the manufacturing of kinase inhibitors for research and development.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1236033-21-8
1-(benzenesulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine
Pharmaceutical intermediate for kinase inhibitors
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
Pharmaceutical intermediate for kinase inhibitors
5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde
Pharmaceutical intermediate for kinase inhibitors
3-Amino-5-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile
Pharmaceutical intermediate for kinase inhibitors
4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic Acid
Pharmaceutical intermediate
(S)-3-Hydroxybutanenitrile
pharmaceutical intermediate
(R)-(-)-Glycidyl-4-nitrobenzenesulfonate
chiral intermediate for active pharmaceutical ingredients
(S)-2-Benzyl-3-(benzyloxy)propanoic acid
Impurity standard for Alvimopan
tert-butyl 4-chloropyrrolo[2,3-d]pyrimidine-7-carboxylate
XGGUTWYJGILAOA-UHFFFAOYSA-N
CC(C)(C)OC(=O)N1C=CC2=C1N=CN=C2Cl